Search

Pulse Biosciences Inc

Gesloten

SectorGezondheidszorg

53.18 1.01

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

53.18

Max

54.54

Belangrijke statistieken

By Trading Economics

Inkomsten

-6.1M

-25M

Verkoop

33K

434K

EPS

-0.36

Winstmarge

-5,681.336

Werknemers

116

EBITDA

-5.5M

-24M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+17.57% upside

Dividenden

By Acuity

Volgende Winsten

5 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

780M

3.4B

Vorige openingsprijs

52.17

Vorige sluitingsprijs

53.18

Pulse Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 okt 2026, 20:07 UTC

Pulse Biosciences Inc shares are advancing, continuing an upward trend since Thursday, despite earlier pulling back from a session high.

22 okt 2026, 20:07 UTC

Pulse Biosciences Inc shares advanced, reflecting a broader upward trend in the market, which has seen a cumulative return of 2.87% since Wednesday's close.

21 okt 2026, 20:07 UTC

Pulse Biosciences Inc is trading modestly higher, aligning with significant overall market gains, and remains above its 20-day moving average.

20 okt 2026, 22:11 UTC

Pulse Biosciences Inc shares declined in after-market trading, following a notable drop at Tuesday's close amid weakness in the Health Care Equipment sub-sector.

16 okt 2026, 20:07 UTC

Pulse Biosciences Inc shares declined significantly, finishing well below their 20-day moving average after a downward trend that began Thursday.

15 okt 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, marking the fifth consecutive session of declines, closing significantly below its 20-day moving average.

14 okt 2026, 21:51 UTC

Pulse Biosciences Inc is trading lower in after-market hours, continuing a trend of three consecutive lower closes amid broader market declines following rising inflation.

13 okt 2026, 20:01 UTC

Social Media

Oppenheimer raises its price target on Pulse Biosciences Inc to 60 from 35 while maintaining an Outperform rating after a non-deal roadshow.

12 okt 2026, 20:06 UTC

Pulse Biosciences Inc shares are declining, continuing a downward trend since Friday.

9 okt 2026, 22:20 UTC

Pulse Biosciences Inc shares are declining in after-market trading, hitting their lowest point since Friday's close after a brief opening gain.

7 okt 2026, 20:07 UTC

Event

Shares of Pulse Biosciences Inc are declining despite the successful enrollment of 164 patients in its NANOPULSE-AF Study, remaining below its 20-day moving average.

5 okt 2026, 20:06 UTC

Pulse Biosciences Inc is advancing, continuing its upward trend since Friday, despite an earlier pullback from a session high. The health care equipment sector shows notable gains.

2 okt 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, closing at their lowest point amid broader market weakness and trading below the 20-day moving average.

1 okt 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, pulling back from a morning peak and remaining below its 20-day moving average.

30 sep 2026, 21:01 UTC

Pulse Biosciences Inc closed lower in after-market trading, marking its fourth consecutive session of decline and remaining significantly below its 20-day moving average.

29 sep 2026, 21:21 UTC

Pulse Biosciences Inc has declined in after-market trading, moving lower since Tuesday's close and falling below its 20-day moving average.

28 sep 2026, 22:21 UTC

Pulse Biosciences Inc saw a significant increase in after-market trading, reaching a notable peak and remaining well above its 20-day moving average.

25 sep 2026, 20:07 UTC

Pulse Biosciences Inc shares fell modestly as the broader market declined, continuing a trend of five consecutive sessions finishing lower.

24 sep 2026, 20:07 UTC

Pulse Biosciences Inc. shares fell sharply, continuing a trend of declines over the last four sessions after an earlier gain in the current session.

23 sep 2026, 19:25 UTC

Pulse Biosciences Inc shares fell modestly, continuing a downward trend observed over the past three sessions, despite initially rising sharply after the market opened.

22 sep 2026, 19:34 UTC

Pulse Biosciences Inc shares fell sharply, declining from Monday's close despite remaining above the 20-day moving average and within the one-month range.

21 sep 2026, 20:12 UTC

Pulse Biosciences Inc declined in after-market trading following Monday's close, remaining flat throughout the session but positioned above its 20-day moving average.

18 sep 2026, 20:02 UTC

Pulse Biosciences Inc shares are rising sharply, reaching a notable high and trading above its 20-day moving average with unusually high volume.

17 sep 2026, 20:07 UTC

Pulse Biosciences Inc is gaining, reflecting positive movement in the health care equipment sector, despite pulling back from an earlier session high.

16 sep 2026, 23:36 UTC

Pulse Biosciences Inc is declining in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

15 sep 2026, 22:02 UTC

News
Event

Pulse Biosciences has an $85 million equity distribution agreement with Mizuho. Shares are trading lower in after-market hours following the announcement.

14 sep 2026, 20:08 UTC

Pulse Biosciences Inc shares are higher today, maintaining a strong position since Friday's close and peaking significantly above the 20-day moving average.

11 sep 2026, 20:08 UTC

Pulse Biosciences Inc is declining in Friday's trading session, continuing a downward trend since Thursday. The stock remains above its 20-day moving average.

10 sep 2026, 20:01 UTC

Pulse Biosciences Inc shares are higher today amid strong trading volume. The stock remains above its 20-day moving average, reflecting broader market trends.

9 sep 2026, 22:01 UTC

Pulse Biosciences shares moved higher in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

Peer Vergelijking

Prijswijziging

Pulse Biosciences Inc Prognose

Koersdoel

By TipRanks

17.57% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 62.333 USD  17.57%

Hoogste 73 USD

Laagste 55 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pulse Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
help-icon Live chat